Providence Capital Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,175
Closed -$34K 305
2021
Q2
$34K Buy
1,175
+125
+12% +$3.79K 0.01% 158
2021
Q1
$33K Sell
1,050
-4,050
-79% -$119K 0.01% 157
2020
Q4
$106K Sell
5,100
-1,400
-22% -$26.1K 0.04% 113
2020
Q3
$101K Buy
6,500
+3,900
+150% +$67.2K 0.05% 91
2020
Q2
$48K Buy
2,600
+500
+24% +$8.81K 0.03% 109
2020
Q1
$33K Buy
2,100
+1,100
+110% +$26.5K 0.02% 127
2019
Q4
$30K Sell
1,000
-1,000
-50% -$26K 0.02% 139
2019
Q3
$44K Buy
2,000
+1,000
+100% +$22.9K 0.03% 112
2019
Q2
$25K Sell
1,000
-1,000
-50% -$23.7K 0.01% 135
2019
Q1
$49K Buy
+2,000
New +$47.8K 0.03% 114

Other funds holding BHC

Providence Capital Advisors's BHC Position: Q3 2021 in Review

Providence Capital Advisors sold out of Bausch Health (BHC) in Q3 2021, closing a stake of 1,175 shares — an estimated $34K sold.

Providence Capital Advisors first reported a position in BHC in Q1 2019 and held it in 10 quarters. The position peaked at $106K in Q4 2020. 346 funds tracked by Wall St. Rank hold BHC as of Q3 2021.

  • Providence Capital Advisors reported no remaining Bausch Health position as of Q3 2021 after selling out during the quarter.
  • Providence Capital Advisors sold 1,175 Bausch Health shares in Q3 2021, an estimated $34K.
  • Providence Capital Advisors first reported a position in Bausch Health in Q1 2019 and held it in 10 quarters.
  • Providence Capital Advisors's Bausch Health position peaked at $106K in Q4 2020.
  • 346 funds tracked by Wall St. Rank held Bausch Health as of Q3 2021.

Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.